Treatment revives old liver cells in lab study, may help prevent Alzheimer’s and heart disease
Peer-Reviewed Publication
Updates every hour. Last Updated: 30-Oct-2026 14:17 ET (30-Oct-2026 18:17 GMT/UTC)
The liver’s job clearing harmful substances from the body is so essential that the organ may have implications for addressing unexpected diseases, including Alzheimer’s and heart disease. A promising example comes from new Keck School of Medicine of USC research published in the Journal of Biological Chemistry.
The study, conducted in aged rats, shows that an experimental drug called cinaciguat reverses effects of aging in the liver. This, in turn, may lower risk for Alzheimer’s disease and clogged arteries. The researchers also revealed what’s behind that rejuvenation, including a specific biochemical pathway used for local communication between liver cells, which suggests a potential therapeutic target.
An analysis of BESTOW trial results indicates that kidney transplant recipients treated with tegoprubart not only have better kidney function but also have better health-related quality of life than those taking today’s standard of care immunosuppressive drug tacrolimus.
The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2026 October 22–25.
Suicidal ideation increased 42.6%, suicide planning by 256.2% and suicide attempts by 263.3% among older U.S. adults from 2021-2024, according to a new UCLA Health and UC San Diego Health study.
Punching a virtual response box or swinging a virtual lightsaber dramatically improved learning on certain tasks, revealing something fundamental about how people learn. New research challenges the long-held view that movement is simply a response to what the brain has already learned, suggesting instead that physical movement can actively shape learning. The findings could inform training in fields such as medicine and aviation, where integrating information and recognizing patterns are critical.